Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Innovate (VATE) EBITDA (2016 - 2025)

Innovate (VATE) has 16 years of EBITDA data on record, last reported at $11.8 million in Q3 2025.

  • For Q3 2025, EBITDA fell 1.67% year-over-year to $11.8 million; the TTM value through Sep 2025 reached $40.0 million, down 47.98%, while the annual FY2024 figure was $65.0 million, 26.46% up from the prior year.
  • EBITDA reached $11.8 million in Q3 2025 per VATE's latest filing, up from $10.4 million in the prior quarter.
  • Across five years, EBITDA topped out at $35.2 million in Q2 2024 and bottomed at -$6.2 million in Q1 2021.
  • Average EBITDA over 5 years is $10.6 million, with a median of $10.4 million recorded in 2025.
  • Peak YoY movement for EBITDA: surged 345.83% in 2022, then plummeted 70.45% in 2025.
  • A 5-year view of EBITDA shows it stood at $14.2 million in 2021, then fell by 9.86% to $12.8 million in 2022, then surged by 59.38% to $20.4 million in 2023, then plummeted by 58.33% to $8.5 million in 2024, then skyrocketed by 38.82% to $11.8 million in 2025.
  • Per Business Quant database, its latest 3 readings for EBITDA were $11.8 million in Q3 2025, $10.4 million in Q2 2025, and $9.3 million in Q1 2025.